Completed Public Health & Healthcare Infection & Immunity

Africa Health Research Institute (GBP record)

In plain English

AI plain-English summary

KwaZulu-Natal carries one of the world's heaviest burdens of HIV and tuberculosis, and a new research institute is merging population-level surveys with laboratory science to find ways to eliminate both diseases. The problem is stark: HIV and TB remain entrenched in this South African province, and standard treatments alone have not stopped transmission. Drug-resistant TB is spreading, and pregnant women with HIV face particular risks to their own health and that of their children. The Africa Health Research Institute will combine decades of community health tracking with cutting-edge experimental medicine to ask five specific questions: how to stop new HIV infections, how to interrupt TB transmission and contain drug resistance, how to improve outcomes for HIV-positive mothers and their infants, how to deliver chronic disease care more effectively, and how migration and economic inequality shape health. If this succeeds, the impact could be practical and measurable—new prevention strategies, better treatment protocols, and health-system changes that reduce infection rates across a real population. The research is applied by design, aimed directly at changing clinical practice and public health policy in a high-burden setting.

View original technical description
Our aim is to reduce the huge burden of HIV and TB in KwaZulu-Natal as a precursor to the eradication of these diseases. This will be facilitated by merging the population based research excellence of the Wellcome Trust (WT)-funded Africa Centre (AC), with the cutting edge laboratory science and experimental medicine approaches of the Howard Hughes Medical Institute (HHMI)- funded KwaZulu-Natal Institute for Research in TB and HIV (K-RITH) to create an exciting, interdisciplinary South African based research initiative. Our 5-year vision is to use basic science, systems biology, health systems and social science research to undertake fundamental discoveries into the susceptibility, transmission and cure of HIV and TB. Our specific questions are: 1. How can new HIV infections best be eliminated? 2. How can TB transmission be interrupted and how can drug-resistance be contained? 3. How can the health of pregnant women with HIV and their offspring be improved? 4. How can we improve the health-system delivery and population-level impact of HIV treatment and other chronic disease care? 5. How is health and wellbeing affected by migration, economic and other inequalities

View the original record at the funder ↗

Researchers

Deenan Pillay (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Centre for Infectious Diseases Research in Africa (CIDRI-Africa)
Africa Health Research Institute - Core Renewal 2023-30 (GBP)
Bioengineering to combat the tuberculosis pandemic
NIHR Global Health Research Group on HIV-associated Fungal Infections
NIHR Global Health Research Group on prevention and management of non-communicable diseases and HIV-infection in Africa, Liverpool School of Tropical Medicine

Original classification

Africa and Asia Programmes

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.